ZYDUSLIFE options
Zydus Lifesciences option chain and implied move
| Metric | Value | Read |
|---|---|---|
| Market-implied move | ±₹20.75 | ±1.84% to the Tuesday, 27 October 2026 expiry, from the at-the-money straddle |
| Implied range | ₹1,108.65 – ₹1,150.15 | What option prices imply, not a forecast of where the stock will trade |
| Max pain | ₹1,150 | The strike at which the largest value of written options would expire worthless |
| Heaviest put strike | ₹1,200 | 2,21,400 contracts — the largest put position on the chain |
| Heaviest call strike | ₹1,200 | 5,65,200 contracts — the largest call position on the chain |
| Put-call ratio | 0.52 | Total put open interest divided by total call open interest across the chain |
| Implied volatility (ATM) | 22.04% | At-the-money implied volatility for the front expiry |
- Market-implied move
- ±₹20.75
- Implied range
- ₹1,109 – ₹1,150
- Max pain
- ₹1,150
- Implied volatility
- 22.04%
±1.84% over 4 days, from the ₹1,130 straddle
What option prices imply, not a forecast of where the stock will trade
₹21 above the close
At the money, for the front expiry
Implied rangeMax painLast close
Heaviest put ₹1,200Heaviest call ₹1,200ATM ₹1,130 · PCR 0.52
At the close on Friday, 23 October 2026, Zydus Lifesciences options were pricing a move of ±₹20.75 by the Tuesday, 27 October 2026 expiry — a range of ₹1,108.65 to ₹1,150.15 against a closing price of ₹1,129.40. The figure is the at-the-money straddle at the ₹1,130 strike, which is what the options market itself is charging for the move to expiry. It describes the price of that expectation, not a forecast MarketCue makes.
Max pain sits at ₹1,150, ₹20.60 above the closing price — the strike at which the largest value of written options would expire worthless. The heaviest put position on the chain is at ₹1,200 with 2,21,400 contracts, and the heaviest call position at ₹1,200 with 5,65,200 contracts. Open interest describes where positions have been built; it is not a commitment by anyone to defend a price.
At-the-money implied volatility was 22.04% for the Tuesday, 27 October 2026 expiry. Realised volatility for Zydus Lifesciences is not yet available for comparison.
This page is a record of where Zydus Lifesciences's chain finished on Friday, 23 October 2026, not a live feed — the next reading follows tomorrow's close. Figures are derived from the NSE option chain via Upstox; max pain, the implied move, put-call ratio and the volatility comparison are MarketCue's own calculations from that data. MarketCue is not a registered investment adviser, research analyst or broker under SEBI regulations, and nothing here is a recommendation to buy or sell any security.
Read the full MarketCue scoring methodology
Source: NSE option chain via Upstox. .
Frequently asked questions
- What move are Zydus Lifesciences options pricing this expiry?
- ±₹20.75, or 1.84%, giving a range of ₹1,108.65 to ₹1,150.15 by Tuesday, 27 October 2026. The figure is derived from the at-the-money straddle at the ₹1,130 strike.
- What is Zydus Lifesciences's max pain?
- ₹1,150 at the last close, against a closing price of ₹1,129.40. Max pain is the strike at which the largest value of written options would expire worthless.
- Where is support and resistance in the Zydus Lifesciences option chain?
- The largest put position sits at ₹1,200 with 2,21,400 contracts, and the largest call position at ₹1,200 with 5,65,200 contracts. Traders commonly read heavy open interest at a strike as a level, though open interest describes positioning rather than any commitment to defend a price.
- What is the lot size for Zydus Lifesciences options?
- 900 shares per lot, with strikes in steps of ₹10. At the implied move of ±₹20.75, one lot corresponds to ±₹18,675 of notional movement.